Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.

Victoria Therese MückeKatja JakobiViola KnopDominique ThomasMarcus Maximilian MückeKai-Henrik PeifferStefan ZeuzemChristoph SarrazinJosef PfeilschifterGeorgios Grammatikos

Published in: PloS one (2018)

In a prospective cohort of patients with a HBeAg-negative HBV infection, serum SLs associated with the virologic course and HBV genotype D. Further studies are required to elucidate SLs as potential novel predictors of the course of HBeAg-negative HBV infection.

Keyphrases

hepatitis b virus
liver failure
hiv infected
antiretroviral therapy
risk assessment